Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

EU flag

EC approves Valneva’s single-dose chikungunya vaccine for use in adults

The virus has been identified in over 110 countries in Europe, Asia, Africa and the Americas

- PMLiVE

The Importance of LGBTQ Diversity in Healthcare

We take a look at the importance of ensuring diversity in the Pharma industry

Mednet

- PMLiVE

Eli Lilly’s Alzheimer’s drug Kisunla granted FDA approval for early symptomatic disease

The amyloid plaque-targeting therapy could result in lower treatment costs and fewer infusions

regeneron headquarters

Regeneron’s odronextamab recommended by CHMP to treat certain lymphomas

Follicular lymphoma and diffuse large B-cell lymphoma are collectively responsible for an estimated 283,000 global cases every year

- PMLiVE

Merck’s pulmonary arterial hypertension therapy receives CHMP recommendation

Approximately 30,000 people in the EU are currently living with the rare blood disorder

- PMLiVE

Dementia – risk factors, research and treatment

There are over ten million new cases of dementia each year worldwide, which translates into one new case every 3.2 seconds

- PMLiVE

Surrogate endpoints in HTA: Reflections on my HTAi panel discussion

Calum Jones (Associate Director – Health Economics, Mtech Access) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health...

Petauri Evidence

- PMLiVE

US and European Market Access for Medical Devices – Free Guide

We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our...

Petauri Evidence

Say Goodbye to Costly Delays – Origins’ Clinical Trial Participant Simulations Have the Answer!

Lack of Patient Involvement in Clinical Trial Designs Causes Major Issues Low recruitment and retention of clinical trials is a key issue faced by many clinical trials. These can lead...

Origins – The Patient Focused Specialists

- PMLiVE

FDA approves Samsung Bioepis’ Stelara biosimilar Pyzchiva for inflammatory conditions

The drug has been authorised to treat plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis

- PMLiVE

AstraZeneca’s Imfinzi/Lynparza regimen recommended by CHMP to treat endometrial cancer

Almost 125,000 cases of endometrial cancer were diagnosed in Europe in 2022

- PMLiVE

Eli Lilly and Radionetics Oncology enter $140m radiopharma partnership

The strategic agreement also gives Lilly the exclusive right to acquire the biotech for $1bn

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links